A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles
首创的抗癌双重 HDAC2/FAK 抑制剂,含有吡啶基-1,2,4-三唑封端的羟肟酸酯/苯甲酰胺
期刊:European Journal of Medicinal Chemistry
影响因子:6
doi:10.1016/j.ejmech.2021.113569
Muhamad Mustafa, Amer Ali Abd El-Hafeez, Dalia Abdelhamid, Gajanan D Katkar, Yaser A Mostafa, Pradipta Ghosh, Alaa M Hayallah, Gamal El-Din A Abuo-Rahma